期刊文献+

下呼吸道革兰阴性菌感染的病原学及耐药分析 被引量:8

Study on the Distribution and Drug Resistance of Gram-negative Bacteria in Patients with Lower Respiratory Tract Infection
暂未订购
导出
摘要 【目的】了解本地区下呼吸道革兰阴性菌(G-)感染者的病原学诊断及对常用抗生素的敏感情况。【方法】回顾性分析2002年1月至2004年12月本院下呼吸道感染住院患者痰标本细菌培养分离及药敏试验结果。【结果】分离率前五位的菌种分别为铜绿假单胞菌(34.8%)、不动杆菌(13.5%)、肺炎克雷伯菌(12.9%)、大肠埃希菌(12.3%)和阴沟肠杆菌(5.2%)。所有G-均有较严重的耐药性,除头孢他啶外,对多数头孢三代药物耐药率高。耐药率较低的抗生素有亚胺培南、美洛培南、哌拉西林/他唑巴坦、头孢吡肟、左氟沙星。其中碳青霉烯类抗生素(亚胺培南、美洛培南)对下呼吸道G-的敏感率在95%以上。本组分离的下呼吸道G-对左氟沙星耐药率较低(33%),对阿米卡星的耐药率高(46%),与其他地区的报道存在较大差异。【结论】下呼吸道G-感染的耐药是目前临床上面临的难题,值得进一步研究,应采用合理的手段降低耐药率的发生。 [Objective]To investigate the distribution of drug resistance of gram-negative bacteria in patients with lower respiratory tract infection in Changde city. [Methods]The results of sputum's culture and antimicrobial susceptibility of patients from 2002 to 2004 were reviewed. [Results]The most common pathogens were Pseudomonas aeruginosa ( 34.8 % ), Acinetobacter spp ( 13.5 % ), Klebsiella pneumoniae ( 12.9 % ), Escherichia coli (12.3 % ), Enterobacter cloacae(5.2 % ). High drug-resistance rates were found among all strains of pathogens to the third generation cephalosporins except ceftazidime. The most sensitive agents against Gram negative organisms were carbopenems(Imipenem, Meropenem), with a susceptibility of more than 95%, followed by Piperacilline/Tazobactam, Cefepime and Levofloxacin. In this study, the drug-resistance rate among gram-negative bacteria from lower respiratory tract to Levofloxacin was 33%, while drug-resistance rate to amikacin was 46% ,different from reports of other area. [Conclusion]Drug resistance is still a serious clinical problem. An unanimous effective strategy for the solution of this problem is urgently needed.
出处 《医学临床研究》 CAS 2006年第10期1628-1630,共3页 Journal of Clinical Research
关键词 呼吸道感染 革兰氏阴性菌 抗药性 微生物 respiratory tract infections gram-negtive bacteria drug resistance, microbial
  • 相关文献

参考文献6

二级参考文献34

  • 1朱德妹,郭蓓宁,汪复.1992年上海地区细菌耐药性监测[J].中国抗生素杂志,1994,19(2):142-146. 被引量:57
  • 2周贵民,张有江,张淑兰,许淑珍,张秀珍,宣天芝,陈民钧,徐英春.北京4家医院对常用较新的16种抗生素的敏感性监测[J].中华微生物学和免疫学杂志,1995,15(4):219-224. 被引量:76
  • 3Kim MY, Oh JI, Paek KS, et al. In vitro and in vivo activities of LB10522, a new catecholic cephalosporin. Antimicrob Agents Chemother, 1996,40:1825.
  • 4Lopez H, Vilches V, Scarano S, et al. Multicentre study of the in vitro evaluation of moxifloxacin and other quinolones against community acquired respiratory pathogens. Int J Antimicrob Agents,2001,18:379.
  • 5Takeoka K, Ichimiya T, Yamasaki T, et al. The in vitro effect of macrolides on the interaction of human polymorphonuclear leukocytes with Pseudomonas aeruginosa in biofilm. Chemotherapy,1998,44:190.
  • 6Corona ALN, Miranda MGN, Leanos BM. Epidemilogic study ofpseudomonas aeruginosa in critical pa tients and resevoirs. Arch Medicine Resistance. 2001,32: 238.
  • 7Jacoby GA, Archer GL. New mechanisms of bacterial resistance to antimicrobial agents. N Engl Med, 1991,324:601.
  • 8Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for beta- lactamases and its correlation with molecular structure. Antimicrob Agents Chemother, 1995 , 39:1211.
  • 9Satake S, Yoneyama H, Nakae T. Role of OmpD2 and chromosomal beta - lactamase in carbapenem resistance in clinical isolates of Pseudomonas aeruginosa. J Antimicrob Chemother, 1991,28:199.
  • 10Mouneimne H, Robert J, Jarlier V, et al. Type Ⅱ topoisomerase mutations in ciprofloxacin - resistant strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother, 1999 , 43: 62.

共引文献1834

同被引文献51

引证文献8

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部